Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT00207779 Completed - Infection Clinical Trials

Prevention of Catheter-Related Bloodstream Infection in Patients With Haemato-Oncological Disease

Start date: May 2005
Phase: Phase 3
Study type: Interventional

We, the researchers at Centre National de Greffe de Moelle Osseuse, have shown in a randomised study (in press), that a low dose of unfractionated heparin (100 IU/kg/daily) was safe and effective to prevent catheter-related bloodstream infection in patients with haemato-oncological disease. The aim of this prospective randomised controlled trial is to compare the incidence of catheter-related bloodstream infection in 2 groups of patients with haemato-oncological disease: - Group A: heparin impregnated catheters - Group B: low-dose unfractionated heparin (100 IU/kg/daily)

NCT ID: NCT00207753 Completed - Hookworm Infection Clinical Trials

Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections

Start date: February 2005
Phase: N/A
Study type: Interventional

The aim of this study is to compare the efficacy and impact on growth of two drug treatments against intestinal worms in schoolchildren from a rural area of Guatemala. According to the World Bank, these intestinal worms are one of the top causes of childhood health problems in many areas of the developing world (The World Bank, 1993). Infected children are more likely to have inadequate nutrition due to the worm infections and are more likely to be shorter in height and weigh less than children who are not infected. After collecting height and weight information, we will split the children into two groups. One group will receive albendazole and the other group will receive combined albendazole/ivermectin. Both groups will be receiving albendazole, the current standard of care treatment. Ivermection is expected to improve efficacy and nutritional benefit as well as add increased scope of treatment for the worm Strongyloides, and ectoparasites such as scabies and head lice. Both treatment regimens and the combination have been used millions of times in the developing world and are safe to use. Co-administration of drugs would be a more efficient use of the opportunity to access schoolchildren and provide deworming treatment.

NCT ID: NCT00207506 Completed - HIV Infections Clinical Trials

Lay Health Advisors for Sexually Transmitted Disease Prevention

Start date: October 2004
Phase: Phase 1/Phase 2
Study type: Interventional

Non-professional community leaders may be at a great advantage in reaching otherwise hard to reach populations for the purpose of advising on sexually transmitted disease (STD) prevention (lay health advisors), health care access, and model health behavior. Latino migrant farm workers are at increased risk for STD and might benefit from such lay health advisors. The study will examine whether this strategy is a useful one for STD prevention in Latino migrant farm workers in rural and small town areas of North Carolina.

NCT ID: NCT00205816 Completed - Clinical trials for Bacterial Infections

Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.

Start date: January 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to provide a mechanism for the emergency use of tigecycline in the appropriate clinical situations. The secondary objective is to evaluate the safety and efficacy of tigecycline in the treatment of patients with selected serious infections where other treatment has not been successful.

NCT ID: NCT00205283 Completed - HIV Infections Clinical Trials

Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection

Start date: August 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the impact of prospective drug level monitoring and dose-adjustment of nelfinavir (NFV) on the clinical and virologic outcomes in a group of HIV-infected patients who have achieved virologic success while receiving a nelfinavir containing highly active antiretroviral therapy (HAART) regimen.

NCT ID: NCT00202488 Completed - Clinical trials for Helicobacter Pylori Infection

The Effect of H. Pylori Infection on Iron Metabolism

Start date: November 2002
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine if Helicobacter pylori (H. pylori) gastritis results in abnormal iron metabolism in patients with iron deficiency anemia (IDA), and to determine if this is due to strain variations in the H. pylori organism.

NCT ID: NCT00198705 Completed - Infectious Disease Clinical Trials

Community Based Interventions to Reduce Neonatal Mortality in Bangladesh

Start date: June 2003
Phase: N/A
Study type: Interventional

This project delivers, promotes and facilitates services related to pregnancy, delivery and newborn care.

NCT ID: NCT00198679 Completed - Clinical trials for Skin Diseases, Infectious

Effect of Chlorhexidine Skin Cleansing on Skin Flora

Start date: March 2004
Phase: Phase 4
Study type: Interventional

Given the potential of skin cleansing with chlorhexidine as a safe, feasible, and cost-effective intervention for reducing neonatal death in developing country settings, this study follows a trial already underway in Nepal to test the impact of a single cleansing of the skin with baby wipes cotaining chlorahexidine.

NCT ID: NCT00198640 Completed - Infection Clinical Trials

AMR of Streptococcus Pneumoniae Carriage Strains

Start date: n/a
Phase: N/A
Study type: Interventional

This study looks at the usage of human antibiotics for treatment of animals in Bangladesh.

NCT ID: NCT00198627 Completed - Infectious Disease Clinical Trials

Etiology, Prevention and Treatment of Neonatal Infections in the Community

Start date: December 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to determine what are the major types of bacteria that cause newborn infections in the community in rural Bangladesh and whether providing an obstetric and neonatal care package will reduce neonatal deaths by 40%.